Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.

Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GYH.

Chest. 2008 Sep;134(3):559-567. doi: 10.1378/chest.08-0350. Epub 2008 Jul 18.

PMID:
18641090
2.

Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Popma JJ, Berger P, Ohman EM, Harrington RA, Grines C, Weitz JI.

Chest. 2004 Sep;126(3 Suppl):576S-599S. Review.

PMID:
15383485
3.

New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.

Rubboli A, Agewall S, Huber K, Lip GY.

Int J Cardiol. 2015 Oct 1;196:133-8. doi: 10.1016/j.ijcard.2015.06.006. Epub 2015 Jun 15. Review.

PMID:
26093527
4.

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.

Rubboli A, Halperin JL, Airaksinen KE, Buerke M, Eeckhout E, Freedman SB, Gershlick AH, Schlitt A, Tse HF, Verheugt FW, Lip GY.

Ann Med. 2008;40(6):428-36. doi: 10.1080/07853890802089786. Review.

PMID:
18608125
5.

Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis.

Chen CF, Chen B, Zhu J, Xu YZ.

Herz. 2015 Dec;40(8):1070-83. doi: 10.1007/s00059-015-4325-0. Epub 2015 Jul 2. Review.

PMID:
26135462
6.

The antithrombotic management of patients on oral anticoagulation undergoing coronary stent implantation: an update.

Rubboli A.

Intern Emerg Med. 2012 Aug;7(4):299-304. doi: 10.1007/s11739-011-0555-1. Epub 2011 Mar 9. Review.

PMID:
21387196
7.

[New aspects on "triple therapy" after coronary stent implantation].

Schlitt A.

Dtsch Med Wochenschr. 2010 Oct;135(41):2033-6. doi: 10.1055/s-0030-1267479. Epub 2010 Oct 5. Review. German.

PMID:
20925012
8.

Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.

Bavishi C, Koulova A, Bangalore S, Sawant A, Chatterjee S, Ather S, Valencia J, Sarafoff N, Rubboli A, Airaksinen JK, Lip GY, Tamis-Holland JE.

Catheter Cardiovasc Interv. 2016 Jul;88(1):E12-22. doi: 10.1002/ccd.26234. Epub 2015 Sep 10. Review.

PMID:
26354765
9.

Risk of bleeding on triple antithrombotic therapy after percutaneous coronary intervention/stenting: a systematic review and meta-analysis.

Andrade JG, Deyell MW, Khoo C, Lee M, Humphries K, Cairns JA.

Can J Cardiol. 2013 Feb;29(2):204-12. doi: 10.1016/j.cjca.2012.06.012. Epub 2012 Oct 2. Review.

PMID:
23036279
10.

Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.

Thompson PL, Verheugt FW.

Clin Ther. 2014 Sep 1;36(9):1176-81. doi: 10.1016/j.clinthera.2014.08.010. Review.

PMID:
25234549
11.

Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention.

D'Ascenzo F, Taha S, Moretti C, Omedè P, Grossomarra W, Persson J, Lamberts M, Dewilde W, Rubboli A, Fernández S, Cerrato E, Meynet I, Ballocca F, Barbero U, Quadri G, Giordana F, Conrotto F, Capodanno D, DiNicolantonio J, Bangalore S, Reed M, Meier P, Zoccai G, Gaita F.

Am J Cardiol. 2015 May 1;115(9):1185-93. doi: 10.1016/j.amjcard.2015.02.003. Epub 2015 Feb 12. Review.

PMID:
25799015
12.

The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.

Rubboli A, Faxon DP, Juhani Airaksinen KE, Schlitt A, Marín F, Bhatt DL, Lip GY.

Thromb Haemost. 2014 Dec;112(6):1080-7. doi: 10.1160/TH14-08-0681. Epub 2014 Oct 9. Review.

PMID:
25298351
13.

Antithrombotic regimens in patients with indication for long-term anticoagulation undergoing coronary interventions-systematic analysis, review of literature, and implications on management.

Deshmukh A, Hilleman DE, Del Core M, Nair CK.

Am J Ther. 2013 Nov-Dec;20(6):654-63. doi: 10.1097/MJT.0b013e31820b867b. Review.

PMID:
21519218
14.

Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.

Pipilis A, Lazaros G, Tsakonas G, Stefanadis C.

Hellenic J Cardiol. 2010 Jul-Aug;51(4):330-7. Review. No abstract available.

15.

Patients with atrial fibrillation undergoing percutaneous coronary intervention. Current concepts and concerns: part I.

Dzeshka MS, Brown RA, Lip GY.

Pol Arch Med Wewn. 2015;125(1-2):73-81. Epub 2015 Dec 23. Review.

16.

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome.

Pham SV, Pham PC, Pham PM, Miller JM, Pham PT, Pham PA.

Drug Des Devel Ther. 2010 Sep 7;4:203-20. doi: 10.2147/DDDT.S12056. Review.

17.

Antithrombotic Therapy in Percutaneous Coronary Intervention.

Yang X, Ghobrial J, Pinto DS.

Interv Cardiol Clin. 2016 Apr;5(2):239-247. doi: 10.1016/j.iccl.2015.12.008. Epub 2016 Feb 12. Review.

PMID:
28582207
18.

Balance of Ischemia and Bleeding in Selecting an Antithrombotic Regimen.

Claessen BE, Dangas GD, Mehran R.

Interv Cardiol Clin. 2013 Oct;2(4):515-525. doi: 10.1016/j.iccl.2013.06.001. Epub 2013 Oct 4. Review.

PMID:
28582180

Supplemental Content

Support Center